Coronary heart disease in women: Highlights of the past 2 years - Stepping stones, milestones and obstructing boulders

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue 4, 2006, Pages 194-202

  Wenger, Nanette K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndromes; Coronary diagnostic testing; Coronary prevention; Percutaneous coronary interventions; Women

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; FIBRIC ACID DERIVATIVE; FIBRINOGEN RECEPTOR ANTAGONIST; FOLIC ACID; GESTAGEN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; OMEGA 3 FATTY ACID; PYRIDOXINE;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; AWARENESS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DIETARY INTAKE; DRUG ELUTING STENT; EVIDENCE BASED MEDICINE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART REHABILITATION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTER; RESTENOSIS; REVIEW; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SEX DIFFERENCE; SMOKING CESSATION; STRESS ECHOCARDIOGRAPHY; STROKE; UNSPECIFIED SIDE EFFECT; UNSTABLE ANGINA PECTORIS; WEIGHT REDUCTION;

ADULT; AGE DISTRIBUTION; AGED; ATTITUDE TO HEALTH; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERLIPIDEMIAS; INCIDENCE; LIFE STYLE; MIDDLE AGED; PRACTICE GUIDELINES; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33645395082     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0516     Document Type: Review

References (31)

1. Agency for Healthcare Research and Quality (2003) Results of Systematic Review of Research on Diagnosis and Treatment of Coronary Heart Disease in Women. Evidence Report/Technology Assessment Number 80, AHRQ Publication Number 03-E034. Washington: United States Department of Health and Human Services, Public Health Services
2. Agency for Healthcare Research and Quality (2003) Diagnosis and Treatment of Coronary Heart Disease in Women: Systematic Reviews of Evidence on Selected Topics. Evidence Report/Technology Assessment Number 81, AHRQ Publication Number 03-E036. Washington: United States Department of Health and Human Services, Public Health Services
3. Wizemann TM and Pardue M-L (Eds); Committee on Understanding the Biology of Sex and Gender Differences, Board on Health Sciences Policy, Institute of Medicine (2001) Exploring the Biological Contributions to Human Health. Does Sex Matter? Washington: National Academy Press
4. Wenger NK (2004) You've come a long way, baby: Cardiovascular health disease in women: Problems and prospects. Circulation 109: 558-560
5. Mosca L et al. (2004) Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 109: 672-693
6. Mosca L et al. (1999) Guide to preventive cardiology for women. AHA/ACC Scientific Statement: Consensus Panel Statement. Circulation 99: 2480-2484
7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421
8. Grundy SM et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110: 227-239
9. Hulley S et al. for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613
10. Rossouw JE et al.; Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333
11. The Women's Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative Randomized Controlled Trial. JAMA 291: 1701-1712
12. Mosca L et al. (2005) National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 111: 499-510
13. Mosca L et al. (2005) Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation 111: 488-493
14. Anon (1993) Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269: 3015-3023
15. 100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294: 326-333
16. Mallik S et al. (2004) Younger women with acute myocardial infarction have highest prevalence of depression [abstract #415]. Circulation 110
17. Vaccarino V et al. for the National Registry of Myocardial Infarction 2 Participants (1999) Sex-based differences in early mortality after myocardial infarction. N Engl J Med 341: 217-225
18. Vaccarino V et al. (2002) Sex differences in hospital mortality alter coronary artery bypass surgery: Evidence for a higher mortality in younger women. Circulation 105: 1176-1181
19. Lee I-M et al. (2005) Vitamin E in the primary prevention of cardiovascular diseaAe and cancer: The Women's Health Study: a randomized controlled trial. JAMA 294: 56-65
20. Ridker PM et al. (2005) A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352: 1293-1304
21. Steering Committee of the Physicians' Health Study Research Group (1989) Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 321: 129-135
22. Gu K et al. (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281: 1291-1297
23. Wexler DJ et al. (2005) Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 28: 514-520
24. Mieres JH et al. (2005) Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 111: 682-696
25. Arad Y et al. (2005) Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St. Francis Heart Study. J Am Coll Cardiol 46: 158-165
26. Blomkalns AL et al.; the CRUSADE Investigators (2005) Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: Large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/ American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 45: 832-837
27. Braunwald E et al. (2002) American College of Cardiology/American Heart Association Committee on the Management of Patients With Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40: 1366-1374
28. Wenger NK (2003) Coronary heart disease: The female heart is vulnerable. Prog Cardiovasc Dis 46:199-229
29. Lansky AJ et al. (2005) Percutaneous coronary intervention and adjunctive pharmacotherapy in women: A statement for healthcare professionals from the American Heart Association. Circulation 111: 940-953
30. Lansky AJ et al.; TAXUS-IV Investigators (2005) Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol 45: 1180-1185
31. Mehilli J et al. (2005) Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction. J Am Coll Cardiol 45: 828-831